Jonathan Monson - 30 Jun 2025 Form 3 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP and CFO
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
30 Jun 2025
Net transactions value
$0
Form type
3
Filing time
30 Jun 2025, 16:51:31 UTC
Previous filing
20 Feb 2024
Next filing
02 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Monson Jonathan EVP and CFO 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH /s/ Susan Thompson, Attorney-in-Fact 30 Jun 2025 0001779170

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BSX Common Stock 34,727 30 Jun 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BSX Restricted Stock Units 30 Jun 2025 Common Stock 3,462 Direct F1, F2, F3
holding BSX Restricted Stock Units 30 Jun 2025 Common Stock 7,066 Direct F3, F4
holding BSX Restricted Stock Units 30 Jun 2025 Common Stock 2,116 Direct F3, F5, F6
holding BSX Restricted Stock Units 30 Jun 2025 Common Stock 990 Direct F3, F7, F8
holding BSX Restricted Stock Units 30 Jun 2025 Common Stock 1,090 Direct F3, F9, F10
holding BSX Restricted Stock Units 30 Jun 2025 Common Stock 3,562 Direct F3, F11
holding BSX Stock Option (Right to Buy) 30 Jun 2025 Common Stock 12,004 $27.09 Direct F12
holding BSX Stock Option (Right to Buy) 30 Jun 2025 Common Stock 14,299 $37.50 Direct F13
holding BSX Stock Option (Right to Buy) 30 Jun 2025 Common Stock 8,605 $40.12 Direct F14
holding BSX Stock Option (Right to Buy) 30 Jun 2025 Common Stock 10,346 $42.16 Direct F15
holding BSX Stock Option (Right to Buy) 30 Jun 2025 Common Stock 10,692 $42.90 Direct F16
holding BSX Stock Option (Right to Buy) 30 Jun 2025 Common Stock 13,180 $44.19 Direct F17
holding BSX Stock Option (Right to Buy) 30 Jun 2025 Common Stock 15,503 $45.88 Direct F18
holding BSX Stock Option (Right to Buy) 30 Jun 2025 Common Stock 12,702 $47.28 Direct F19
holding BSX Stock Option (Right to Buy) 30 Jun 2025 Common Stock 10,543 $56.14 Direct F20
holding BSX Stock Option (Right to Buy) 30 Jun 2025 Common Stock 14,180 $64.99 Direct F21
holding BSX Stock Option (Right to Buy) 30 Jun 2025 Common Stock 7,165 $106.14 Direct F22
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.
F2 This amount represents the unvested portion of RSUs awarded on February 12, 2024, which will continue to vest in three remaining installments on the anniversary of the date of grant.
F3 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
F6 This amount represents the unvested portion of RSUs awarded on February 14, 2023, which will continue to vest in two remaining installments on the anniversary of the date of grant.
F7 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F8 This amount represents the unvested portion of RSUs awarded on February 16, 2022, which will continue to vest in one remaining installment on the anniversary of the date of grant.
F9 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on August 2, 2022, the first anniversary of the date of grant.
F10 This amount represents the unvested portion of RSUs awarded on August 2, 2021, which will continue to vest in one remaining installment on the anniversary of the date of grant.
F11 Shares of common stock will be issued to the reporting person in full on December 1, 2026, the third anniversary of the date of grant.
F12 Grant to the reporting person of an option to purchase 12,004 shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
F13 Grant to the reporting person of an option to purchase 14,299 shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F14 Grant to the reporting person of an option to purchase 8,605 shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
F15 Grant to the reporting person of an option to purchase 10,346 shares of common stock vesting in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
F16 Grant to the reporting person of an option to purchase 10,692 shares of common stock vesting in four equal annual installments beginning on July 1, 2020, the first anniversary of the date of grant.
F17 Grant to the reporting person of an option to purchase 13,180 shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F18 Grant to the reporting person of an option to purchase 15,503 shares of common stock vesting in four equal annual installments beginning on August 2, 2022, the first anniversary of the date of grant.
F19 Grant to the reporting person of an option to purchase 12,702 shares of common stock vesting in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
F20 Grant to the reporting person of an option to purchase 10,543 shares of common stock vesting in full on December 1, 2026, the third anniversary of the date of grant.
F21 Grant to the reporting person of an option to purchase 14,180 shares of common stock vesting in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.
F22 Grant to the reporting person of an option to purchase 7,165 shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.

Remarks:

monsonpoa.txt